Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Shunyalabs.ai has launched ZeroMed, a next-generation automatic speech recognition (ASR) system designed specifically for healthcare environments. The company calls it “a breakthrough domain-optimized ...

Epstein sees a clear direction of travel in private markets. “The trend line is toward standardized data and repeatable ...

The plain, though somewhat striking, reality is that Advanced Micro Devices’ ($AMD) share price has more than doubled this ...

NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic ...

When New York City’s congestion pricing plan launched on January 5, 2025, the sky did not fall—but traffic did. After months ...

Network participation on Solana has dropped sharply, with the seven-day average of daily active addresses falling to about ...

Shares of Engene Holdings Inc. (NASDAQ:ENGN) were trading at $10.34, up $4.33, or 72%, on word of additional preliminary data from the pivotal cohort of its ongoing phase II Legend trial testing ...

Five AI-focused stocks led by Microsoft, Nvidia, and Amazon earn strong analyst ratings with multi-year growth catalysts ...

Amazon.com, Inc. is a top long-term investment pick among Magnificent 7 stocks. Click for my updated look at AMZN stock post ...

The research aim is to develop an intelligent agent for cybersecurity systems capable of detecting abnormal user behavior ...